VertiAI™ marks a paradigm shift in vestibular diagnostics as the world’s first clinically validated AI system specifically developed for diagnosing Benign Paroxysmal Positional Vertigo (BPPV). This breakthrough technology transforms what was once a complex, subjective, and time-consuming process into a precise, objective, and near-instant diagnostic experience.
Designed for balance clinics, audiologists, neurologists, and primary care providers, VertiAI™ tackles key challenges such as misdiagnosis, treatment delays, and unnecessary patient suffering. Seamlessly integrated with ZEHNIT products—VertiGoggles™ or VertiChair™ — VertiAI™ enables clinicians to make accurate BPPV diagnoses in under 60 seconds, reducing patient discomfort, lowering healthcare costs, and elevating diagnostic confidence across all levels of care.
Clinical Impact & Value
● Significantly reduces misdiagnosis compared to traditional BPPV evaluation methods
● Eliminates repeated testing and incorrect repositioning maneuvers
● Minimizes patient discomfort caused by unnecessary or ineffective treatments
● Enables accurate diagnosis even for less experienced clinicians
● Brings expert-level diagnostic capability to primary care and rural settings
ZEHNIT's systems go beyond traditional 2D analysis by incorporating full 3D eye movement tracking, including torsional components, to capture the complete complexity of BPPV-related nystagmus. This capability significantly enhances diagnostic accuracy and forms the foundation for more reliable interpretation—whether performed manually by clinicians or automatically via VertiAI™.
Using a novel combination of 1D convolution and self-attention algorithms, VertiAI™ processes time-series data directly from VertiGoggles™ or VertiChair™ - without complex video processing. Results are delivered in under 60 seconds, using 99.999% fewer computational resources than traditional video-based AI methods.
VertiAI™ has been clinically validated across a wide spectrum of BPPV presentations, including:
• Posterior canal BPPV (typical cases)
• Horizontal canal BPPV, including canalithiasis and cupulolithiasis
• High-precision negative case screening, minimizing false positives and preventing unnecessary treatments
VertiAI™ runs efficiently on standard clinical computers, making advanced BPPV diagnosis accessible across a wide range of care settings, including:
• Community healthcare centers
• Primary care clinics
• Hospitals with limited IT infrastructure
• Remote and underserved medical facilities
VertiAI™ incorporates key clinical factors—including patient positioning, individual characteristics, and diagnostic context—into its analysis algorithm. Fully aligned with international vertigo diagnostic guidelines and expert consensus recommendations, the system ensures both clinical relevance and practical applicability across diverse care settings.
